Subscribe
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma
Articles
Articles
Idiopathic Castleman Disease: Clinical Features and Therapeutic Options
ASH 2014 - Castleman's Disease
,
ASH Highlights
Conference Correspondent
Read More
Restoration of Health with Siltuximab in Multicentric Castleman Disease
ASH 2014 - Castleman's Disease
,
ASH Highlights
Conference Correspondent
Read More
Siltuximab Efficacy in Multicentric Castleman’s Disease Is Independent of Baseline Symptom Burden
ASH 2014 - Castleman's Disease
,
ASH Highlights
Conference Correspondent
Read More
Adding Rituximab to CHOP Improves Clinical Outcomes in Mantle-Cell Lymphoma
ASH 2014 - Castleman's Disease
,
ASH Highlights
Conference Correspondent
Read More
Long-Term Maintenance with Rituximab in Elderly Patients with Mantle-Cell Lymphoma
ASH 2014 - Castleman's Disease
,
ASH Highlights
Conference Correspondent
Read More
Antagonism of Immune Effector Function by Ibrutinib or Obinutuzumab versus Rituximab
ASH 2014 - Castleman's Disease
,
ASH Highlights
Conference Correspondent
Read More
Ibrutinib Alone or in Combination with Dexamethasone for Relapsed/Refractory Multiple Myeloma
ASH 2014 - Castleman's Disease
,
ASH Highlights
Conference Correspondent
Read More
Data from the SPARK Study: Mutational Analysis of Patients with Primary Resistance to Ibrutinib in Relapsed/Refractory Mantle-Cell Lymphoma
ASH 2014 - Castleman's Disease
,
ASH Highlights
Conference Correspondent
Read More
International Research Agenda for Multicentric Castleman’s Disease
ASH 2014 - Castleman's Disease
,
ASH Highlights
Conference Correspondent
Read More
Updates on Treatments for Castleman’s Disease
ASH 2014 - Castleman's Disease
,
ASH Highlights
Conference Correspondent
Read More
Page 208 of 329
205
206
207
208
209
210
211
Top Trending Articles
1.
Immunotherapy Helps Navy Veteran Beat Stage 4 Lung Cancer
2.
HOPA Highlights: What's New in 2025?
3.
Peer Navigation Intervention Aims to Boost Childhood Cancer Clinical Trial Participation
Home
Issues
Online First
Latest Issue
Issue Archive
Special Issues
Browse By Topic
Personalized Medicine
Economics & Value
FDA Approvals, News & Updates
COVID-19
Cholangiocarcinoma
View All Topics ›
Conference Correspondent
ESMO 2025 - Wrap-Up: Triple-Negative Breast Cancer
ASCO 2025 - Wrap-Up: Triple-Negative Breast Cancer
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Prostate Cancer Diagnostics Monthly Minutes
Webinars
Quick Quiz
Press Releases
Association for Value-Based Cancer Care
VBCM
Value-Based Care in Myeloma